Yes!!! I’ve been in this since .19 a share. Closed at 9.91 today and finally got FDA approval.
The stock ripped all the Band-Aids off before getting approval. It has zero debt, cash in hand, low cash burn, 50 million dollar milestone payment hitting with labeling. Short squeeze coming from all the shorts that bet wrong.
“KemPharm may be eligible for up to $468 million in regulatory and sales milestone payments, as well as tiered royalty payments, on a product-by-product basis for net sales, with potential percentages up to the mid-twenties for U.S. net sales, and up to the mid-single digits of net sales in each country outside of the U.S.”
Submitted March 03, 2021 at 12:37AM by Coboblack https://ift.tt/3ba5O5S